van Houte Hans

van Houte Hans is listed in filings as Chief Financial Officer at Nurix Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 5, 2026, including sale activity. Recent filings connect the profile to Nurix Therapeutics, Inc. (NRIX). The current snapshot covers public activity from Jul 30, 2024 to May 5, 2026. Reported amounts are shown as $223.3K to $39.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.